Drug eluting stents have been linked to a potential risk of blood clots, which could occur months or even years after the tiny devices are implanted into a previously clogged artery. As a result, thousands of individuals have suffered serious and potentially fatal injuries.

The lawyers at Saiontz & Kirk, P.A. previously reviewed drug eluting stent lawsuits against the manufacturers of the Johnson & Johnson Cypher Stent and Boston Scientific Taxus Stent, for individuals who suffered a:

  • Heart Attack
  • Reclogging of the Artery
  • Death

New cases are no longer being accepted. This page is maintained for informational purposes only.


Studies suggested that drug eluting stents may carry a statistically significant increase in the risk of late stent thrombosis (blood clots at the site of the heart stent). The danger extends for much longer than the manufacturers previously warned about.

The manufacturers of drug eluding stents failed to adequately warn consumers about the dangers associated with their products.

Profits were placed before patient safety when they failed to fully disclose the serious danger and actively attempted to downplay the risk.

The warning label for the Cypher stent only recommended individuals receive three months of follow up care on a blood thinner and the Taxus stent only recommends six months.  However, studies have indicated that patients receiving drug eluting stents need to be followed for years after the procedure.

To reduce the risk of potentially fatal blood clots, most doctors now recommend that patients take a blood thinner, such as Plavix, for the rest of their life. However, the continued long-term use of such medications carries an additional risk of Plavix side effects, such as severe gastrointestinal bleeding, ulcers, heart attacks, strokes and death.


Drug eluting stent lawsuits were previously investigated and reviewed by the lawyers at Saiontz & Kirk, P.A. for individuals who suffered a heart attack, reclogging of the artery or death. New cases are no longer being accepted. This page is maintained for informational purposes only.